Compare AdaptHealth Corp (AHCO) vs Boston Beer Company Inc (SAM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Boston Beer Company Inc — how do they compare? AdaptHealth Corp trades at $10.06 (market cap $1.38B), while Boston Beer Company Inc trades at $179.54 (market cap $1.91B). The key difference: Boston Beer Company Inc is the larger of the two by market cap, and AdaptHealth Corp is trading nearer its 52-week high, Boston Beer Company Inc nearer its low. Which is the better fit depends on your goals.
| AHCO | SAM | |
|---|---|---|
Market Cap | $1.38B | $1.91B |
Sector | Health | Consumer Staples |
52-Week High | $13.38 | $260.05 |
52-Week Low | $8.68 | $161.08 |
Enterprise Value | $3.33B | $1.78B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Boston Beer (SAM) trades at $183.16, down 0.25% with bearish technical signals. The stock shows mixed fundamentals with a P/E of 22.66 and P/S of 0.99, but negative net income margin of -3.15% and ROE of -7.75%. Recent Q1 2026 earnings missed expectations, though Q3 and Q4 2025 beat estimates. Cash flow improved to $11.56M net in 2025 after a negative 2024. Analyst consensus price target is $233.40 with 74% hold ratings.
SAM faces headwinds from declining volume growth and brand pressure, but maintains strong gross margins at 48.7%. The 27% upside to consensus target offers potential, though execution risks and competitive beverage market pose challenges. Institutional sentiment is cautious with limited buy ratings despite positive cash flow recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →
